 | • レポートコード：MRC2-11QY04284 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、90ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療機器・消耗品 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はプラズマ治療薬のグローバル市場について調査・分析したレポートです。種類別（ヒト血清タンパク質、血漿由来凝固因子、免疫グロブリン、高免疫グロブリン）市場規模、用途別（研究所および機関、病院、独立型血液銀行）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別プラズマ治療薬の競争状況、市場シェア ・世界のプラズマ治療薬市場：種類別市場規模 2015年-2020年（ヒト血清タンパク質、血漿由来凝固因子、免疫グロブリン、高免疫グロブリン） ・世界のプラズマ治療薬市場：種類別市場規模予測 2021年-2026年（ヒト血清タンパク質、血漿由来凝固因子、免疫グロブリン、高免疫グロブリン） ・世界のプラズマ治療薬市場：用途別市場規模 2015年-2020年（研究所および機関、病院、独立型血液銀行） ・世界のプラズマ治療薬市場：用途別市場規模予測 2021年-2026年（研究所および機関、病院、独立型血液銀行） ・北米のプラズマ治療薬市場分析：米国、カナダ ・ヨーロッパのプラズマ治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのプラズマ治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のプラズマ治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのプラズマ治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Baxter、CSL Behring、Grifols Therapeutics、Octapharma、Abeona Therapeutics、ADMA Biologics、Amag Pharmaceuticals、Antares Pharma、BioDelivery Sciences、Bio Products Laboratory、Biota Pharmaceuticals、Biotest Pharmaceuticals、China Biologic Products ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Plasma, pale yellow in color, is the component of the blood.
To calculate the market size, the report considers revenue generated from the sales of branded therapies derived from the various fractions of plasma such as albumin, immunoglobulins, coagulation factors, hyperimmune globulins, and A1PI.
Market Analysis and Insights: Global Plasma Therapeutics Market
The global Plasma Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Plasma Therapeutics Scope and Market Size
Plasma Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Plasma Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Baxter
CSL Behring
Grifols Therapeutics
Octapharma
Abeona Therapeutics
ADMA Biologics
Amag Pharmaceuticals
Antares Pharma
BioDelivery Sciences
Bio Products Laboratory
Biota Pharmaceuticals
Biotest Pharmaceuticals
China Biologic Products
Market segment by Type, the product can be split into
Human Serum Protein
Plasma-Derived Clotting Factor
Immunoglobulins
High Immunoglobulins
Market segment by Application, split into
Research Laboratories And Institutions
Hospitals
Stand-Alone Blood Banks
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Plasma Therapeutics Revenue
1.4 Market by Type
1.4.1 Global Plasma Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Human Serum Protein
1.4.3 Plasma-Derived Clotting Factor
1.4.4 Immunoglobulins
1.4.5 High Immunoglobulins
1.5 Market by Application
1.5.1 Global Plasma Therapeutics Market Share by Application: 2020 VS 2026
1.5.2 Research Laboratories And Institutions
1.5.3 Hospitals
1.5.4 Stand-Alone Blood Banks
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Plasma Therapeutics Market Perspective (2015-2026)
2.2 Global Plasma Therapeutics Growth Trends by Regions
2.2.1 Plasma Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Plasma Therapeutics Historic Market Share by Regions (2015-2020)
2.2.3 Plasma Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Plasma Therapeutics Market Growth Strategy
2.3.6 Primary Interviews with Key Plasma Therapeutics Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Plasma Therapeutics Players by Market Size
3.1.1 Global Top Plasma Therapeutics Players by Revenue (2015-2020)
3.1.2 Global Plasma Therapeutics Revenue Market Share by Players (2015-2020)
3.1.3 Global Plasma Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Plasma Therapeutics Market Concentration Ratio
3.2.1 Global Plasma Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Plasma Therapeutics Revenue in 2019
3.3 Plasma Therapeutics Key Players Head office and Area Served
3.4 Key Players Plasma Therapeutics Product Solution and Service
3.5 Date of Enter into Plasma Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Plasma Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Plasma Therapeutics Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Plasma Therapeutics Market Size by Application (2015-2020)
5.2 Global Plasma Therapeutics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Plasma Therapeutics Market Size (2015-2020)
6.2 Plasma Therapeutics Key Players in North America (2019-2020)
6.3 North America Plasma Therapeutics Market Size by Type (2015-2020)
6.4 North America Plasma Therapeutics Market Size by Application (2015-2020)
7 Europe
7.1 Europe Plasma Therapeutics Market Size (2015-2020)
7.2 Plasma Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Plasma Therapeutics Market Size by Type (2015-2020)
7.4 Europe Plasma Therapeutics Market Size by Application (2015-2020)
8 China
8.1 China Plasma Therapeutics Market Size (2015-2020)
8.2 Plasma Therapeutics Key Players in China (2019-2020)
8.3 China Plasma Therapeutics Market Size by Type (2015-2020)
8.4 China Plasma Therapeutics Market Size by Application (2015-2020)
9 Japan
9.1 Japan Plasma Therapeutics Market Size (2015-2020)
9.2 Plasma Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Plasma Therapeutics Market Size by Type (2015-2020)
9.4 Japan Plasma Therapeutics Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Plasma Therapeutics Market Size (2015-2020)
10.2 Plasma Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Plasma Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Plasma Therapeutics Market Size by Application (2015-2020)
11 India
11.1 India Plasma Therapeutics Market Size (2015-2020)
11.2 Plasma Therapeutics Key Players in India (2019-2020)
11.3 India Plasma Therapeutics Market Size by Type (2015-2020)
11.4 India Plasma Therapeutics Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Plasma Therapeutics Market Size (2015-2020)
12.2 Plasma Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Plasma Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Plasma Therapeutics Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Baxter
13.1.1 Baxter Company Details
13.1.2 Baxter Business Overview
13.1.3 Baxter Plasma Therapeutics Introduction
13.1.4 Baxter Revenue in Plasma Therapeutics Business (2015-2020))
13.1.5 Baxter Recent Development
13.2 CSL Behring
13.2.1 CSL Behring Company Details
13.2.2 CSL Behring Business Overview
13.2.3 CSL Behring Plasma Therapeutics Introduction
13.2.4 CSL Behring Revenue in Plasma Therapeutics Business (2015-2020)
13.2.5 CSL Behring Recent Development
13.3 Grifols Therapeutics
13.3.1 Grifols Therapeutics Company Details
13.3.2 Grifols Therapeutics Business Overview
13.3.3 Grifols Therapeutics Plasma Therapeutics Introduction
13.3.4 Grifols Therapeutics Revenue in Plasma Therapeutics Business (2015-2020)
13.3.5 Grifols Therapeutics Recent Development
13.4 Octapharma
13.4.1 Octapharma Company Details
13.4.2 Octapharma Business Overview
13.4.3 Octapharma Plasma Therapeutics Introduction
13.4.4 Octapharma Revenue in Plasma Therapeutics Business (2015-2020)
13.4.5 Octapharma Recent Development
13.5 Abeona Therapeutics
13.5.1 Abeona Therapeutics Company Details
13.5.2 Abeona Therapeutics Business Overview
13.5.3 Abeona Therapeutics Plasma Therapeutics Introduction
13.5.4 Abeona Therapeutics Revenue in Plasma Therapeutics Business (2015-2020)
13.5.5 Abeona Therapeutics Recent Development
13.6 ADMA Biologics
13.6.1 ADMA Biologics Company Details
13.6.2 ADMA Biologics Business Overview
13.6.3 ADMA Biologics Plasma Therapeutics Introduction
13.6.4 ADMA Biologics Revenue in Plasma Therapeutics Business (2015-2020)
13.6.5 ADMA Biologics Recent Development
13.7 Amag Pharmaceuticals
13.7.1 Amag Pharmaceuticals Company Details
13.7.2 Amag Pharmaceuticals Business Overview
13.7.3 Amag Pharmaceuticals Plasma Therapeutics Introduction
13.7.4 Amag Pharmaceuticals Revenue in Plasma Therapeutics Business (2015-2020)
13.7.5 Amag Pharmaceuticals Recent Development
13.8 Antares Pharma
13.8.1 Antares Pharma Company Details
13.8.2 Antares Pharma Business Overview
13.8.3 Antares Pharma Plasma Therapeutics Introduction
13.8.4 Antares Pharma Revenue in Plasma Therapeutics Business (2015-2020)
13.8.5 Antares Pharma Recent Development
13.9 BioDelivery Sciences
13.9.1 BioDelivery Sciences Company Details
13.9.2 BioDelivery Sciences Business Overview
13.9.3 BioDelivery Sciences Plasma Therapeutics Introduction
13.9.4 BioDelivery Sciences Revenue in Plasma Therapeutics Business (2015-2020)
13.9.5 BioDelivery Sciences Recent Development
13.10 Bio Products Laboratory
13.10.1 Bio Products Laboratory Company Details
13.10.2 Bio Products Laboratory Business Overview
13.10.3 Bio Products Laboratory Plasma Therapeutics Introduction
13.10.4 Bio Products Laboratory Revenue in Plasma Therapeutics Business (2015-2020)
13.10.5 Bio Products Laboratory Recent Development
13.11 Biota Pharmaceuticals
10.11.1 Biota Pharmaceuticals Company Details
10.11.2 Biota Pharmaceuticals Business Overview
10.11.3 Biota Pharmaceuticals Plasma Therapeutics Introduction
10.11.4 Biota Pharmaceuticals Revenue in Plasma Therapeutics Business (2015-2020)
10.11.5 Biota Pharmaceuticals Recent Development
13.12 Biotest Pharmaceuticals
10.12.1 Biotest Pharmaceuticals Company Details
10.12.2 Biotest Pharmaceuticals Business Overview
10.12.3 Biotest Pharmaceuticals Plasma Therapeutics Introduction
10.12.4 Biotest Pharmaceuticals Revenue in Plasma Therapeutics Business (2015-2020)
10.12.5 Biotest Pharmaceuticals Recent Development
13.13 China Biologic Products
10.13.1 China Biologic Products Company Details
10.13.2 China Biologic Products Business Overview
10.13.3 China Biologic Products Plasma Therapeutics Introduction
10.13.4 China Biologic Products Revenue in Plasma Therapeutics Business (2015-2020)
10.13.5 China Biologic Products Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Plasma Therapeutics Key Market Segments
Table 2. Key Players Covered: Ranking by Plasma Therapeutics Revenue
Table 3. Ranking of Global Top Plasma Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Plasma Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Human Serum Protein
Table 6. Key Players of Plasma-Derived Clotting Factor
Table 7. Key Players of Immunoglobulins
Table 8. Key Players of High Immunoglobulins
Table 9. Global Plasma Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Plasma Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Plasma Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Plasma Therapeutics Market Share by Regions (2015-2020)
Table 13. Global Plasma Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Plasma Therapeutics Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Plasma Therapeutics Market Growth Strategy
Table 19. Main Points Interviewed from Key Plasma Therapeutics Players
Table 20. Global Plasma Therapeutics Revenue by Players (2015-2020) (Million US$)
Table 21. Global Plasma Therapeutics Market Share by Players (2015-2020)
Table 22. Global Top Plasma Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Plasma Therapeutics as of 2019)
Table 23. Global Plasma Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Plasma Therapeutics Product Solution and Service
Table 26. Date of Enter into Plasma Therapeutics Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Plasma Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 29. Global Plasma Therapeutics Market Size Share by Type (2015-2020)
Table 30. Global Plasma Therapeutics Revenue Market Share by Type (2021-2026)
Table 31. Global Plasma Therapeutics Market Size Share by Application (2015-2020)
Table 32. Global Plasma Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 33. Global Plasma Therapeutics Market Size Share by Application (2021-2026)
Table 34. North America Key Players Plasma Therapeutics Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Plasma Therapeutics Market Share (2019-2020)
Table 36. North America Plasma Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 37. North America Plasma Therapeutics Market Share by Type (2015-2020)
Table 38. North America Plasma Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 39. North America Plasma Therapeutics Market Share by Application (2015-2020)
Table 40. Europe Key Players Plasma Therapeutics Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Plasma Therapeutics Market Share (2019-2020)
Table 42. Europe Plasma Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Plasma Therapeutics Market Share by Type (2015-2020)
Table 44. Europe Plasma Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Plasma Therapeutics Market Share by Application (2015-2020)
Table 46. China Key Players Plasma Therapeutics Revenue (2019-2020) (Million US$)
Table 47. China Key Players Plasma Therapeutics Market Share (2019-2020)
Table 48. China Plasma Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 49. China Plasma Therapeutics Market Share by Type (2015-2020)
Table 50. China Plasma Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 51. China Plasma Therapeutics Market Share by Application (2015-2020)
Table 52. Japan Key Players Plasma Therapeutics Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Plasma Therapeutics Market Share (2019-2020)
Table 54. Japan Plasma Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Plasma Therapeutics Market Share by Type (2015-2020)
Table 56. Japan Plasma Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Plasma Therapeutics Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Plasma Therapeutics Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Plasma Therapeutics Market Share (2019-2020)
Table 60. Southeast Asia Plasma Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Plasma Therapeutics Market Share by Type (2015-2020)
Table 62. Southeast Asia Plasma Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Plasma Therapeutics Market Share by Application (2015-2020)
Table 64. India Key Players Plasma Therapeutics Revenue (2019-2020) (Million US$)
Table 65. India Key Players Plasma Therapeutics Market Share (2019-2020)
Table 66. India Plasma Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 67. India Plasma Therapeutics Market Share by Type (2015-2020)
Table 68. India Plasma Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 69. India Plasma Therapeutics Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Plasma Therapeutics Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Plasma Therapeutics Market Share (2019-2020)
Table 72. Central & South America Plasma Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Plasma Therapeutics Market Share by Type (2015-2020)
Table 74. Central & South America Plasma Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Plasma Therapeutics Market Share by Application (2015-2020)
Table 76. Baxter Company Details
Table 77. Baxter Business Overview
Table 78. Baxter Product
Table 79. Baxter Revenue in Plasma Therapeutics Business (2015-2020) (Million US$)
Table 80. Baxter Recent Development
Table 81. CSL Behring Company Details
Table 82. CSL Behring Business Overview
Table 83. CSL Behring Product
Table 84. CSL Behring Revenue in Plasma Therapeutics Business (2015-2020) (Million US$)
Table 85. CSL Behring Recent Development
Table 86. Grifols Therapeutics Company Details
Table 87. Grifols Therapeutics Business Overview
Table 88. Grifols Therapeutics Product
Table 89. Grifols Therapeutics Revenue in Plasma Therapeutics Business (2015-2020) (Million US$)
Table 90. Grifols Therapeutics Recent Development
Table 91. Octapharma Company Details
Table 92. Octapharma Business Overview
Table 93. Octapharma Product
Table 94. Octapharma Revenue in Plasma Therapeutics Business (2015-2020) (Million US$)
Table 95. Octapharma Recent Development
Table 96. Abeona Therapeutics Company Details
Table 97. Abeona Therapeutics Business Overview
Table 98. Abeona Therapeutics Product
Table 99. Abeona Therapeutics Revenue in Plasma Therapeutics Business (2015-2020) (Million US$)
Table 100. Abeona Therapeutics Recent Development
Table 101. ADMA Biologics Company Details
Table 102. ADMA Biologics Business Overview
Table 103. ADMA Biologics Product
Table 104. ADMA Biologics Revenue in Plasma Therapeutics Business (2015-2020) (Million US$)
Table 105. ADMA Biologics Recent Development
Table 106. Amag Pharmaceuticals Company Details
Table 107. Amag Pharmaceuticals Business Overview
Table 108. Amag Pharmaceuticals Product
Table 109. Amag Pharmaceuticals Revenue in Plasma Therapeutics Business (2015-2020) (Million US$)
Table 110. Amag Pharmaceuticals Recent Development
Table 111. Antares Pharma Business Overview
Table 112. Antares Pharma Product
Table 113. Antares Pharma Company Details
Table 114. Antares Pharma Revenue in Plasma Therapeutics Business (2015-2020) (Million US$)
Table 115. Antares Pharma Recent Development
Table 116. BioDelivery Sciences Company Details
Table 117. BioDelivery Sciences Business Overview
Table 118. BioDelivery Sciences Product
Table 119. BioDelivery Sciences Revenue in Plasma Therapeutics Business (2015-2020) (Million US$)
Table 120. BioDelivery Sciences Recent Development
Table 121. Bio Products Laboratory Company Details
Table 122. Bio Products Laboratory Business Overview
Table 123. Bio Products Laboratory Product
Table 124. Bio Products Laboratory Revenue in Plasma Therapeutics Business (2015-2020) (Million US$)
Table 125. Bio Products Laboratory Recent Development
Table 126. Biota Pharmaceuticals Company Details
Table 127. Biota Pharmaceuticals Business Overview
Table 128. Biota Pharmaceuticals Product
Table 129. Biota Pharmaceuticals Revenue in Plasma Therapeutics Business (2015-2020) (Million US$)
Table 130. Biota Pharmaceuticals Recent Development
Table 131. Biotest Pharmaceuticals Company Details
Table 132. Biotest Pharmaceuticals Business Overview
Table 133. Biotest Pharmaceuticals Product
Table 134. Biotest Pharmaceuticals Revenue in Plasma Therapeutics Business (2015-2020) (Million US$)
Table 135. Biotest Pharmaceuticals Recent Development
Table 136. China Biologic Products Company Details
Table 137. China Biologic Products Business Overview
Table 138. China Biologic Products Product
Table 139. China Biologic Products Revenue in Plasma Therapeutics Business (2015-2020) (Million US$)
Table 140. China Biologic Products Recent Development
Table 141. Research Programs/Design for This Report
Table 142. Key Data Information from Secondary Sources
Table 143. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Plasma Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. Human Serum Protein Features
Figure 3. Plasma-Derived Clotting Factor Features
Figure 4. Immunoglobulins Features
Figure 5. High Immunoglobulins Features
Figure 6. Global Plasma Therapeutics Market Share by Application: 2020 VS 2026
Figure 7. Research Laboratories And Institutions Case Studies
Figure 8. Hospitals Case Studies
Figure 9. Stand-Alone Blood Banks Case Studies
Figure 10. Plasma Therapeutics Report Years Considered
Figure 11. Global Plasma Therapeutics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Plasma Therapeutics Market Share by Regions: 2020 VS 2026
Figure 13. Global Plasma Therapeutics Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Plasma Therapeutics Market Share by Players in 2019
Figure 16. Global Top Plasma Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Plasma Therapeutics as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Plasma Therapeutics Revenue in 2019
Figure 18. North America Plasma Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Plasma Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Plasma Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Plasma Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Plasma Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Plasma Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Plasma Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Bottom-up and Top-down Approaches for This Report
Figure 26. Data Triangulation
Figure 27. Key Executives Interviewed
ヒト血漿由来治療薬の世界市場（～2026年） Market Analysis and Insights: Global Human Plasma-Derived Therapeutics Market The global Human Plasma-Derived Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Human Plasma-Derived Therapeutics Scope and Mar…- 多血小板血漿の世界市場（～2026年） Platelet rich plasma (PRP) is a blood plasma product in which concentration of platelets is elevated four to eight times than normal blood platelet concentration.PRP is also called platelet rich gel, platelet enriched plasma and platelet enriched gel. Market Analysis and Insights: Global Platelet Ri…
- 血漿成分分離器の世界市場（～2026年） Plasma are generally used to increase blood volume or it can be separated into individual plasma proteins such as fibrinogen, factor VIII, anti-thrombin III and factor IX. Improving healthcare infrastructure is expected to boost the growth of the plasma component separator market. Market Analysis an…
- 治療用血漿交換の世界市場（～2026年） Plasma exchange is a procedure that separates and removes plasma from the blood in order to eliminate a disease substance circulating in the plasma. The red blood cells, white blood cells, and platelets are returned to the patient, along with a prescribed replacement fluid. Plasma exchange is widely…
- 血漿プロテアーゼC1阻害剤治療の世界市場（～2026年） This report on the plasma protease C1-inhibitors treatment market analyzes the current and future scenario of the global market. Large number of acute HAE patients is increasing the usage of plasma protease C1-inhibitors treatment. Increasing prevalence of rare diseases around the world, promising p…